ASPEN PHARMACARE HOLDINGS LIMITED - Notice regarding the release of Financial Results for the six months ended 31 December 2025 and Results Presentation

Notice regarding the release of Financial Results for the six months ended 31 December 2025 and Results Presentation

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
("Aspen" or "the Company")


NOTICE REGARDING THE RELEASE OF ASPEN'S FINANCIAL RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2025 
AND RESULTS PRESENTATION

Shareholders are advised that Aspen intends to release its results for the six months ended 31 December
2025 on Tuesday, 3 March 2026 via JSE SENS at 13:00 (SAST, GMT+2), with a presentation to members of the
investment community, in-person, at the Absa Healthcare Conference, hosted at The Vineyard Hotel, Cape
Town and via webcast on Wednesday, 4 March 2026 at 08:30 (SAST, GMT+2).

To attend the in-person presentation, interested persons are requested to RSVP by following the link
provided here: https://web-eur.cvent.com/event/c0a7b08c-a910-4ad1-ade7-5cd47cbc405d/register or
through the invitation sent through The Vault Exchange.

All interested stakeholders are invited to watch the live webcast which can be accessed using the link
provided here: https://www.corpcam.com/Aspen04032026

The slides accompanying the presentation will be available on the home page of the Aspen website
(www.aspenpharma.com) shortly before the commencement of the presentation on Wednesday, 4 March
2026.

A playback of the webcast will be made available on our website approximately 2 hours after the
presentation.



Durban
06 February 2026

Sponsor:
Investec Bank Limited

Date: 06-02-2026 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.